FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284704036> ?p ?o ?g. }

• W4284704036 abstract "Abstract Relapsed or refractory (R/R) acute myeloid leukemia (AML) has a poor prognosis. In this study, we evaluated chimeric antigen receptor (CAR) T cell therapy targeting CLL-1 in adults with R/R AML patients. Patients received conditioning chemotherapy with cyclophosphamide (500 mg/m 2 ) and fludarabine (30 mg/m 2 ) for 3 days and an infusion of a dose of 1–2 × 10 6 CAR-T cells/kg. The incidence of dose-limiting toxicity was the primary endpoint. Ten patients were treated, and all developed cytokine release syndrome (CRS); 4 cases were low-grade, while the remaining 6 were considered high-grade CRS. No patient developed CAR-T cell-related encephalopathy syndrome (CRES). Severe pancytopenia occurred in all patients. Two patients died of severe infection due to chronic agranulocytosis. The complete response (CR)/CR with incomplete hematologic recovery (CRi) rate was 70% ( n = 7/10). The median follow-up time was 173 days (15–488), and 6 patients were alive at the end of the last follow-up. CAR-T cells showed peak expansion within 2 weeks. Notably, CLL-1 is also highly expressed in normal granulocytes, so bridging hematopoietic stem cell transplantation (HSCT) may be a viable strategy to rescue long-term agranulocytosis due to off-target toxicity. In conclusion, this study is the first to demonstrate the positive efficacy and tolerable safety of CLL-1 CAR-T cell therapy in adult R/R AML." @default.
• W4284704036 created "2022-07-08" @default.
• W4284704036 creator A5014536732 @default.
• W4284704036 creator A5022098811 @default.
• W4284704036 creator A5026513884 @default.
• W4284704036 creator A5032547940 @default.
• W4284704036 creator A5034579880 @default.
• W4284704036 creator A5034649465 @default.
• W4284704036 creator A5036465902 @default.
• W4284704036 creator A5037341948 @default.
• W4284704036 creator A5053461832 @default.
• W4284704036 creator A5055051950 @default.
• W4284704036 creator A5059955952 @default.
• W4284704036 creator A5074140059 @default.
• W4284704036 creator A5077931358 @default.
• W4284704036 date "2022-07-07" @default.
• W4284704036 modified "2023-10-18" @default.
• W4284704036 title "First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia" @default.
• W4284704036 cites W2004639735 @default.
• W4284704036 cites W2100883771 @default.
• W4284704036 cites W2621998980 @default.
• W4284704036 cites W2765972717 @default.
• W4284704036 cites W2783779434 @default.
• W4284704036 cites W2898794856 @default.
• W4284704036 cites W3022543485 @default.
• W4284704036 cites W3142830907 @default.
• W4284704036 cites W4205382255 @default.
• W4284704036 cites W4206409537 @default.
• W4284704036 cites W4223582500 @default.
• W4284704036 doi "https://doi.org/10.1186/s13045-022-01308-1" @default.
• W4284704036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35799191" @default.
• W4284704036 hasPublicationYear "2022" @default.
• W4284704036 type Work @default.
• W4284704036 citedByCount "25" @default.
• W4284704036 countsByYear W42847040362022 @default.
• W4284704036 countsByYear W42847040362023 @default.
• W4284704036 crossrefType "journal-article" @default.
• W4284704036 hasAuthorship W4284704036A5014536732 @default.
• W4284704036 hasAuthorship W4284704036A5022098811 @default.
• W4284704036 hasAuthorship W4284704036A5026513884 @default.
• W4284704036 hasAuthorship W4284704036A5032547940 @default.
• W4284704036 hasAuthorship W4284704036A5034579880 @default.
• W4284704036 hasAuthorship W4284704036A5034649465 @default.
• W4284704036 hasAuthorship W4284704036A5036465902 @default.
• W4284704036 hasAuthorship W4284704036A5037341948 @default.
• W4284704036 hasAuthorship W4284704036A5053461832 @default.
• W4284704036 hasAuthorship W4284704036A5055051950 @default.
• W4284704036 hasAuthorship W4284704036A5059955952 @default.
• W4284704036 hasAuthorship W4284704036A5074140059 @default.
• W4284704036 hasAuthorship W4284704036A5077931358 @default.
• W4284704036 hasBestOaLocation W42847040361 @default.
• W4284704036 hasConcept C121332964 @default.
• W4284704036 hasConcept C126322002 @default.
• W4284704036 hasConcept C142424586 @default.
• W4284704036 hasConcept C194409129 @default.
• W4284704036 hasConcept C203014093 @default.
• W4284704036 hasConcept C2776090121 @default.
• W4284704036 hasConcept C2776694085 @default.
• W4284704036 hasConcept C2776755627 @default.
• W4284704036 hasConcept C2777408962 @default.
• W4284704036 hasConcept C2778729363 @default.
• W4284704036 hasConcept C2779263901 @default.
• W4284704036 hasConcept C2779382419 @default.
• W4284704036 hasConcept C2780007613 @default.
• W4284704036 hasConcept C2780850621 @default.
• W4284704036 hasConcept C2911091166 @default.
• W4284704036 hasConcept C3875195 @default.
• W4284704036 hasConcept C71924100 @default.
• W4284704036 hasConcept C87355193 @default.
• W4284704036 hasConcept C8891405 @default.
• W4284704036 hasConcept C90924648 @default.
• W4284704036 hasConceptScore W4284704036C121332964 @default.
• W4284704036 hasConceptScore W4284704036C126322002 @default.
• W4284704036 hasConceptScore W4284704036C142424586 @default.
• W4284704036 hasConceptScore W4284704036C194409129 @default.
• W4284704036 hasConceptScore W4284704036C203014093 @default.
• W4284704036 hasConceptScore W4284704036C2776090121 @default.
• W4284704036 hasConceptScore W4284704036C2776694085 @default.
• W4284704036 hasConceptScore W4284704036C2776755627 @default.
• W4284704036 hasConceptScore W4284704036C2777408962 @default.
• W4284704036 hasConceptScore W4284704036C2778729363 @default.
• W4284704036 hasConceptScore W4284704036C2779263901 @default.
• W4284704036 hasConceptScore W4284704036C2779382419 @default.
• W4284704036 hasConceptScore W4284704036C2780007613 @default.
• W4284704036 hasConceptScore W4284704036C2780850621 @default.
• W4284704036 hasConceptScore W4284704036C2911091166 @default.
• W4284704036 hasConceptScore W4284704036C3875195 @default.
• W4284704036 hasConceptScore W4284704036C71924100 @default.
• W4284704036 hasConceptScore W4284704036C87355193 @default.
• W4284704036 hasConceptScore W4284704036C8891405 @default.
• W4284704036 hasConceptScore W4284704036C90924648 @default.
• W4284704036 hasIssue "1" @default.
• W4284704036 hasLocation W42847040361 @default.
• W4284704036 hasLocation W42847040362 @default.
• W4284704036 hasLocation W42847040363 @default.
• W4284704036 hasLocation W42847040364 @default.
• W4284704036 hasOpenAccess W4284704036 @default.
• W4284704036 hasPrimaryLocation W42847040361 @default.
• W4284704036 hasRelatedWork W2251648452 @default.
• W4284704036 hasRelatedWork W2916176185 @default.

• next